Navigation Links
Speed and ecstasy associated with depression in teenagers
Date:4/18/2012

This press release is available in French.

A five year study conducted with thousands of local teenagers by University of Montreal researchers reveals that those who used speed (meth/ampthetamine) or ecstasy (MDMA) at fifteen or sixteen years of age were significantly more likely to suffer elevated depressive symptoms the following year. "Our findings are consistent with other human and animal studies that suggest long-term negative influences of synthetic drug use," said co-author Frdric N. Brire of the School Environment Research Group at the University of Montreal. "Our results reveal that recreational MDMA and meth/amphetamine use places typically developing secondary school students at greater risk of experiencing depressive symptoms." Ecstasy and speed-using grade ten students were respectively 1.7 and 1.6 times more likely to be depressed by the time they reached grade eleven.

The researchers worked with data provided by 3,880 students enrolled at schools in disadvantaged areas of Quebec. The participants were asked a series of questions that covered their drug use what they had used in the past year or ever in their life and their home life. Depressive symptoms were established by using a standard epidemiological evaluation tool. 310 respondents reported using MDMA (8%) and 451 used meth/amphetamines (11.6%). 584 of all respondents were identified as having elevated depressive symptoms (15.1%). The range of questions that the researchers asked enabled them to adjust their statistics to take into account other factors likely to affect the psychological state of the student, such as whether there was any conflict between the parents and the participant. "This study takes into account many more influencing factors than other research that has been undertaken regarding the association between drugs and depression in teenagers," Brire said. "However, it does have its limitations, in particular the fact that we cannot entirely rule out the effects of drug combinations and that we do not know the exact contents of MDMA and meth/amphetamine pills."

The study's authors would like to do further research into how drug combinations affect a person's likelihood to suffer depression and they are keen to learn more about the differences between adults and adolescents in this area. "Our study has important public health implications for adolescent populations," said Jean-Sbastien Fallu, a professor at the University of Montreal and study co-author. "Our results reinforce the body of evidence in this field and suggest that adolescents should be informed of the potential risks associated with MDMA and meth/amphetamine use."


'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Related medicine news :

1. Drug Seems to Speed Recovery After Traumatic Brain Injury
2. Autoinjector Offers Safe, Speedy Care for Life-Threatening Seizures: Study
3. Can Walking Speed, Hand Grip in Middle Age Predict Dementia Risk?
4. Knee Arthritis May Speed Up Process Linked to Cell Aging
5. Zebrafish may help speed drug discovery
6. CSHL team introduces automated imaging to greatly speed whole-brain mapping efforts
7. FDA Moves to Speed Development of Artificial Pancreas Systems
8. MIT: New algorithm could substantially speed up MRI scans
9. Speedy 3-D X-rays in the operating room
10. Slower Walking Speed Linked to Surgical Risk in Elderly
11. Bicycle May Speed Up Parkinsons Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate ... and video system brings songs, movies, TV shows and much more apps for user ... high-definition sound. An immersive view of 1280 x 720 provides crisp images with remarkable ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud ... The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in drug ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the top ... and genders. And the need for advanced services is growing. , Project WE ... care program, in collaboration with their non-profit partners in their fight against cancer and ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for ... analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements ...
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Now in its seventh year, the ... most successful at developing and commercialising innovation. ... The Index can be ... to two different companies in early phase, which would make ... analysis of each company,s performance between 2011 and 2016, the 2017 ranking ...
(Date:2/27/2017)... Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the ... and Chief Executive Officer (CEO) and member of the Board ... Richard Love , interim President and CEO who will continue ... has over 20 years of experience in hematology, oncology and ... . "On behalf of CTI BioPharma,s Board, ...
(Date:2/27/2017)... The Dutch secure mobile phone ... at the security level RESTRICTED. The solution thus meets the ... the communication of classified information. ... Sectra and Samsung have a strategic ... solution. Sectra Tiger/R is developed by Sectra under guidance from ...
Breaking Medicine Technology: